Antigen-specific membrane fusion mediated by the haemagglutinin protein of influenza A virus: Separation of attachment and fusion functions on different molecules

Gene Therapy

Volumn 6, Issue 4, 1999, Pages 694-702

  Patterson, S M ^a   Swainsbury, R ^a   Routledge, E G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Fusion; Gene therapy; Haemagglutinin; Influenza; Receptor specificity

Indexed keywords

HEMAGGLUTININ;

AMINO ACID SEQUENCE; ANTIGEN SPECIFICITY; ARTICLE; CHO CELL; CONTROLLED STUDY; ERYTHROCYTE; GENE THERAPY; GENETIC ENGINEERING; IMMUNOBLOTTING; INFLUENZA VIRUS A; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; RECEPTOR BINDING; VIRUS GENE;

ANIMALS; CHO CELLS; CRICETINAE; ERYTHROCYTES; GENETIC ENGINEERING; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; MEMBRANE FUSION; NITROHYDROXYIODOPHENYLACETATE; PROTEIN BINDING; VIRAL ENVELOPE PROTEINS;

CRICETINAE; CRICETULUS GRISEUS; INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0032946250     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300842     Document Type: Article

References (45)

1. Cosset F-L et al. Packaging cells for avian-leukosis virus-based vectors with various host ranges. J Virol 1992; 66: 5671-5676.
2. Dong JY, Roth MG, Hunter E. A chimaeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range. J Virol 1992; 66: 7374-7382.
3. Burns JC et al. Vesicular stomatitis virus G glycoprotein pseudo-typed retroviral vectors: concentration to very high titre and efficient gene transfer into mammalian cells. Proc Natl Acad Sci USA 1993; 90: 8033-8037.
4. Russell SJ, Hawkins RE, Winter G. Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res 1993; 21: 1081-1085.
5. Somia NV, Zoppe M, Verma IM. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acad Sci USA 1995; 92: 7570-7574.
6. Chu T-HT, Dornburg R. Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J Virol 1995; 69: 2659-2663.
7. Marin M et al. Targeted infection of human cells via major histo-compatibility complex class 1 molecules by Moloney murine leukemia virus-derived viruses displaying single chain antibody fragment-envelope fusion proteins. J Virol 1996; 70: 2957-2962.
8. Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 1994; 266: 1373-1376.
9. Han X, Kasahara N, Kan YW. Ligand-directed retroviral targeting of human breast cancer cells. Proc Natl Acad Sci USA 1995; 92: 9747-9751.
10. Cosset F-L et al. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol 1995; 69: 6314-6322.
11. Valsesia-Wittmann S et al. Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J Virol 1994; 68: 4609-4619.
12. Albritton LM, Tseng L, Scadden D, Cunningham JM. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane spanning protein and confers susceptibility to virus infection. Cell 1989; 57: 659-666.
13. Wang H, Kavanaugh MP, North RA, Kabat D. Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature 1991; 352: 729-731.
14. Kasahara N, Dozy AM, Kan YW. Targeting retroviral vectors to specific cells: response. Science 1995; 269: 417.
15. Valsesia-Wittmann S et al. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU. J Virol 1996; 70: 2059-2064.
16. Ager S et al. Retroviral display of antibody fragments: interdomain spacing strongly influences vector infectivity. Hum Gene Ther 1996; 7: 2157-2164.
17. Wilson IA, Skehel JJ, Wiley DC. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 angstroms resolution. Nature 1981; 289: 366-373.
18. Weis WI et al. Structure of the influenza haemagglutinin complexed with its receptor, sialic acid. Nature 1988; 333: 426-431.
19. Bullough PA, Hughson FM, Skehel JJ, Wiley DC. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 1994; 371: 37-43.
20. Gething MJ, Henneberry J, Sambrook J. Fusion activity of the hemagglutinin of influenza virus. Curr Top Mem Trans 1988; 32: 337-364.
21. White J, Helenius A, Gething M-J. Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion. Nature 1982; 300: 658-659.
22. Wharton SA, Skehel JJ, Wiley DC. Studies of influenza haemagglutinin-mediated membrane fusion. Virol 1986; 149: 27-35.
23. Ellens H et al. Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing liposomes: role of hemagglutinin surface density. Biochem 1990; 29: 9697-9707.
24. Hatziioannou T, Valsesia-Wittmann S, Russell SJ, Cosset F-L. Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses. J Virol 1998; 72: 5313-5317.
25. Verhoeyen M et al. Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75. Nature 1980; 286: 771-776.
26. Daniels RS, Douglas AR, Skehel JJ, Wiley DC. Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus mediated membrane fusion. J Gen Virol 1983; 64: 1657-1662.
27. Wiley DC, Wilson IA, Skehel JJ. Structural identification of the antibody-binding sites of Hong-Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 1981; 289: 373-378.
28. Kido H et al. Isolation and characterisation of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. J Biol Chem 1992; 267: 13573-13579.
29. Scheiblauer H, Reinacher M, Tashiro M, Rott R. Interactions between bacteria and influenza A virus in the development of influenza pneumonia. J Infect Dis 1992; 166: 783-791.
30. Skehel JJ et al. Changes in the conformation of influenza virus haemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci USA 1982; 79: 968-972.
31. Gething M-J, McCammon K, Sambrook J. Expression of wild-type and mutant forms of influenza hemagglutinin: the role of folding in intracellular transport. Cell 1986; 46: 939-950.
32. Copeland CS et al. Assembly of influenza hemagglutinin trimers and its role in intracellular transport. J Cell Biol 1986; 103: 1179-1191.
33. Wharton SA et al. Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO J 1995; 14: 240-246.
34. Bentz J, Ellens H, Alford D. An architecture for the fusion site of influenza hemagglutinin. FEBS Lett 1990; 276: 1-5.
35. Martin J et al. Studies of the binding properties of influenza hemagglutinin receptor-site mutants. Virol 1998; 241: 101-111.
36. Bernard O, Hozumi N, Tonegawa S. Sequences of mouse immunoglobulin light chain genes before and after somatic changes. Cell 1978; 15: 1133-1144.
37. Neuberger MS, Rajewsky K. Switch from hapten-specific immunoglobulin M to immunoglobulin D secretion in a hybrid mouse cell line. Proc Natl Acad Sci USA 1981; 78: 1138-1142.
38. b family of antibodies: somatic mutation evident in a γ2a variable region. Cell 1981; 24: 625-637.
39. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 1987; 196: 947-950.
40. Gunning P et al. Human β-actin expression vector system directs high level accumulation of antisense transcripts. Proc Natl Acad Sci USA 1987; 84: 4831-1835.
41. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
42. Carroll SM, Higa HH, Paulson JC. Different cell-surface receptor determinants of antigenically similar influenza virus hemagglutinins. J Biol Chem 1981; 256: 8357-8363.
43. Michaelsen TE, Garred P, Aase A. Human IgG subclass pattern of inducing complement mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration. Eur J Immunol 1991; 21: 11-16.
44. Doxsey SJ, Sambrook J, Helenius A, White JM. An efficient method for introducing macromolecules into living cells. J Cell Biol 1985; 101: 19-27.
45. Rechsteiner MC. Transfer of macromolecules using erythrocyte ghosts. In: Shay J (ed). Techniques in Somatic Cell Genetics. Plenum Press: New York, 1982, pp 385-398.